CH504452A - Verfahren zur Herstellung von Morpholinderivaten - Google Patents

Verfahren zur Herstellung von Morpholinderivaten

Info

Publication number
CH504452A
CH504452A CH1697067A CH1697067A CH504452A CH 504452 A CH504452 A CH 504452A CH 1697067 A CH1697067 A CH 1697067A CH 1697067 A CH1697067 A CH 1697067A CH 504452 A CH504452 A CH 504452A
Authority
CH
Switzerland
Prior art keywords
preparation
morpholine derivatives
morpholine
derivatives
Prior art date
Application number
CH1697067A
Other languages
German (de)
English (en)
Inventor
Blakeney Mallion Keith
William Turner Ralph
Henry Todd Alexander
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Priority to CH506670A priority Critical patent/CH505849A/de
Priority to CH1707670A priority patent/CH531528A/de
Publication of CH504452A publication Critical patent/CH504452A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1697067A 1966-12-28 1967-12-01 Verfahren zur Herstellung von Morpholinderivaten CH504452A (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CH506670A CH505849A (de) 1966-12-28 1967-12-01 Verfahren zur Herstellung von Morpholinderivaten
CH1707670A CH531528A (de) 1967-12-01 1970-11-17 Verfahren zur Herstellung von neuen Morpholinderivaten und deren Säureadditionssalzen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5796367 1966-12-28
GB57963/66A GB1138405A (en) 1966-12-28 1966-12-28 Morpholine derivatives

Publications (1)

Publication Number Publication Date
CH504452A true CH504452A (de) 1971-03-15

Family

ID=26267707

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1697067A CH504452A (de) 1966-12-28 1967-12-01 Verfahren zur Herstellung von Morpholinderivaten

Country Status (7)

Country Link
US (1) US3714161A (https=)
BE (1) BE708557A (https=)
CH (1) CH504452A (https=)
DE (1) DE1695295C2 (https=)
FR (2) FR1571341A (https=)
GB (1) GB1138405A (https=)
NL (1) NL157303B (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959273A (en) * 1966-12-28 1976-05-25 Imperial Chemical Industries Limited Morpholine derivatives
US3857839A (en) * 1969-06-20 1974-12-31 Ici Ltd For cyclising 1-aryloxy-3 beta-substituted ethylamino-2-propanols
BE759013R (fr) * 1969-11-17 1971-05-17 Ici Ltd Derives de la
BE758766A (fr) * 1969-11-17 1971-05-10 Ici Ltd Nouveaux derives de la morpholine et de la
US3806595A (en) * 1971-08-09 1974-04-23 Ici Ltd Method of producing anorexia
GB1382526A (en) * 1972-08-11 1975-02-05 Ici Ltd Morpholine derivatives
US4033951A (en) * 1973-12-13 1977-07-05 Imperial Chemical Industries Limited Morpholine derivative of a 1,4-benzothiazin-3-one
US4079135A (en) * 1973-12-13 1978-03-14 Imperial Chemical Industries Limited Morpholine derivatives as antidepressants
CA1064927A (en) * 1975-01-29 1979-10-23 Yuji Kawashima Process of producing 2-(indenyloxymethyl) morpholine derivatives
US4109088A (en) * 1975-01-29 1978-08-22 Yamanouchi Pharmaceutical Co., Ltd. 2-(indenyloxymethyl) morpholine derivatives
DE2530860C2 (de) * 1975-07-10 1987-01-15 Yoshitomi Pharmaceutical Industries, Ltd., Osaka 2-[2-(2-Thenyl)-phenoxymethyl]-morpholin-Derivate
US4005084A (en) * 1975-07-10 1977-01-25 Yoshitomi Pharmaceutical Industries, Ltd. Thienylmethyl phenoxy morpholine compounds
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
US4241059A (en) * 1979-12-17 1980-12-23 E. R. Squibb & Sons, Inc. 6-[(Aryloxy)methyl]-2-morpholinemethanol derivatives and use thereof
FR2534915B1 (fr) * 1982-10-26 1985-10-25 Lafon Labor Nouveaux derives de 2-(phenoxymethyl)-morpholine, utilisation en therapeutique et procede de preparation
FR2575158B1 (fr) * 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
FR2612926B1 (fr) * 1987-03-24 1989-06-09 Adir Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
PT684237E (pt) * 1993-02-10 2000-04-28 Yamanouchi Pharma Co Ltd Derivado de morfolina
CA2422055A1 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
BRPI0510453A (pt) * 2004-04-30 2007-10-30 Warner Lambert Co composto substituìdos com morfolina para o tratamento de distúrbios do sistema nervoso central
DK2076508T3 (da) 2006-10-18 2011-02-21 Pfizer Prod Inc Biaryl-ether-urinstof-forbindelser
EP2341912B1 (en) 2008-09-05 2014-01-22 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
MX347218B (es) 2010-04-12 2017-04-20 Supernus Pharmaceuticals Inc Metodos para producir sales de viloxazina y polimorfos novedosos de las mismas.
ES2546492T3 (es) 2010-05-21 2015-09-24 Research Triangle Institute Derivados de 1-fenilmorfolina como análogos de hidroxibupropion para tratar drogodependencia
AU2011255276B2 (en) 2010-05-21 2016-09-22 Research Triangle Institute Phenylmorpholines and analogues thereof
AU2013217013B2 (en) * 2012-02-08 2017-04-20 Supernus Pharmaceuticals, Inc. Modified release formulations of viloxazine
EP4317141A1 (en) 2022-08-04 2024-02-07 Curia Spain S.A.U. Process and intermediates for the preparation of viloxazine and other 2-substituted morpholine derivatives
WO2025219523A1 (en) 2024-04-19 2025-10-23 Cambrex Profarmaco Milano S.R.L. "intermediates and processes for the preparation of viloxazine"

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH356451A (de) * 1957-04-05 1961-08-31 Geigy Ag J R Verfahren zur Herstellung von neuen Morpholinverbindungen

Also Published As

Publication number Publication date
NL6717719A (https=) 1968-07-01
GB1138405A (en) 1969-01-01
NL157303B (nl) 1978-07-17
DE1695295A1 (de) 1975-03-20
FR1571341A (https=) 1969-06-20
FR7557M (https=) 1969-12-29
BE708557A (https=) 1968-06-27
US3714161A (en) 1973-01-30
DE1695295C2 (de) 1984-01-05

Similar Documents

Publication Publication Date Title
CH501647A (de) Verfahren zur Herstellung von Piperazinderivaten
CH492676A (de) Verfahren zur Herstellung von 1-Phenyl-2-aminoäthanol-Derivaten
CH504452A (de) Verfahren zur Herstellung von Morpholinderivaten
CH491119A (de) Verfahren zur Herstellung von N6-Aralkyl-adenosin-derivaten
CH489517A (de) Verfahren zur Herstellung von N-Acylsydnoniminderivaten
CH460020A (de) Verfahren zur Herstellung von Piperazinderivaten
CH513911A (de) Verfahren zur Herstellung von Piperazinderivaten
CH478133A (de) Verfahren zur Herstellung von Isothiazol-Derivaten
CH494206A (de) Verfahren zur Herstellung von Alkanolaminderivaten
CH493465A (de) Verfahren zur Herstellung von Alkanolaminderivaten
CH461461A (de) Verfahren zur Herstellung von Derivaten des N-Acylvinylamins
CH510640A (de) Verfahren zur Herstellung von Diarylcyclopropan-Derivaten
CH486484A (de) Verfahren zur Herstellung von Dibenzothiazinderivaten
CH496005A (de) Verfahren zur Herstellung von Piperazin-Derivaten
CH457452A (de) Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten
CH489509A (de) Verfahren zur Herstellung von Derivaten des Piperazins
CH458362A (de) Verfahren zur Herstellung von Piperazinderivaten
CH481901A (de) Verfahren zur Herstellung von 16-Methylen-19-norprogesteron-derivaten
CH521358A (de) Verfahren zur Herstellung von Phenazinderivaten
CH496663A (de) Verfahren zur Herstellung von 2-Benzyliden-cyclopentanonderivaten
CH471146A (de) Verfahren zur Herstellung von neuen Morpholinderivaten
CH458370A (de) Verfahren zur Herstellung von Imidazolidinonsulfonamidderivaten
CH497411A (de) Verfahren zur Herstellung von neuen Homogonan-Derivaten
CH488720A (de) Verfahren zur Herstellung von Isothiazolderivaten
CH471831A (de) Verfahren zur Herstellung von 1-Hydroxy-östradiol-Derivaten

Legal Events

Date Code Title Description
PL Patent ceased